PITX2 and neoplasm: Furthermore, while shRNA control vector transfection responded to RGS treatment with reduced YUMM3.3 tumor growth in vivo, tumors with attenuated CD40 expression (shRNA_CDS and shRNA_UTR) were resistant to RGS-mediated inhibition of tumor growth (Fig. 5 k).